InvestorsObserver is giving China Biologic Products Holdings Inc (CBPO) an Analyst Rating Rank of 6, meaning CBPO is ranked higher by analysts than 6% of stocks. The average projection by analysts for CBPO is $103 over the next 12 months and analyst’s classify the stock as a Sell
Why are Analyst Ratings Important?
Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers.
InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.
What's Happening With China Biologic Products Holdings Inc Stock Today?
China Biologic Products Holdings Inc (CBPO) stock has risen 2.25% while the S&P 500 is lower by -1.19% as of 2:15 PM on Thursday, Sep 17. CBPO has risen $2.48 from the previous closing price of $109.81 on volume of 104,836 shares. Over the past year the S&P 500 has gained 11.26% while CBPO has risen 8.87%. CBPO earned $3.95 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 28.45.
Click Here to get the full report on China Biologic Products Holdings Inc (CBPO) Stock.
